Is Revive Therapeutics Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Revive Therapeutics Ltd (RVV.CN) is currently classified as NOT HALAL as of June 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Revive Therapeutics Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Revive Therapeutics Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Revive Therapeutics Ltd?

Muslim investors may consider investing in Revive Therapeutics Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Revive Therapeutics Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of Revive Therapeutics Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Revive Therapeutics Ltd updated?

The Shariah compliance status of Revive Therapeutics Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Revive Therapeutics Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Revive Therapeutics Ltd?

You can check the latest Shariah compliance status of Revive Therapeutics Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

RVV.CN Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: June 30, 2025

Report Source: 2025 3rd Quarter Report

Revive Therapeutics Ltd. Stock Analysis RVV.CN

Canada Health Care Nano Cap Report: Q3, 2025

Revive Therapeutics Ltd. engages in the research, development, and commercialization of drugs for disorders and infectious diseases. The company is headquartered in Toronto, Ontario. The company went IPO on 2013-07-12. The firm is focused on the research and development of therapeutics for infectious diseases and medical countermeasures. The company is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. The firm is also advancing the development of Psilocybin and molecular hydrogen therapeutics through various programs. The firm's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).

Key Statistics of Revive Therapeutics Ltd (RVV.CN)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

CAD0.06CAD0.08

Today's Open

CAD0.03

Volume

2.94M

P/E Ratio (TTM)

52 Week Range

CAD0.01CAD0.08

Market Cap

12.56M

Avg. Volume

201.57K

Dividend Yield

Financial Metrics & Statements of Revive Therapeutics Ltd (RVV.CN)

FAQ's for Revive Therapeutics Ltd (RVV.CN)

According to Musaffa’s Shariah screening methodology, Revive Therapeutics Ltd (RVV.CN) is currently classified as NOT HALAL as of June 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.